Myomo today priced an upcoming offering, looking to raise approximately $10 million to support its myoelectric braces and orthotics designed for individuals with neuromuscular disorders.
In the offering, the Cambridge, Mass.-based company is looking to float approximately 4.2 million shares and warrants to purchase an additional 4.2 million shares at $2.40 per share. Warrants offered in the round will be exercisable immediately at a price of $2.95 per share, set to expire on December 4, 2022.
Registration is open for DeviceTalks Boston! Join us on June 5-6, 2019, as we explore the trends and technology that are shaping the future of the medical device industry.